Health ❯ Medicine ❯ Oncology

Cancer Research

Pancreatic Cancer Metastasis Gene Therapy Immunotherapy Tumor Immunology Clinical Trials Tumor Microenvironment Prostate Cancer Head and Neck Cancer Colon Cancer Synovial Sarcoma Cancer Growth and Spread KRAS Mutations Erythropoietin Biomarkers and Diagnostics Neuroblastoma Lymphoma Cell Biology Cell Cycle Dynamics Therapeutic Development Immunogenic Cell Death Sinonasal Squamous Cell Carcinoma Leukemia Biomarkers Chemotherapy Resistance Benzaldehyde Therapy Resistance Metabolic Gene Targets Drug Development Non-Small Cell Lung Cancer Bone Metastases Natural Killer Cells Metabolism Microbiome and Cancer Small Cell Lung Cancer Nuclear Hypertrophy Extracellular Vesicles Triple-Negative Breast Cancer Chemoresistance Gene Mutations Bladder Cancer Cancer Stem Cells Acute Myeloid Leukemia Cellular Biology Experimental Therapies Endogenous Retroviruses Drug Repurposing Fibrolamellar Carcinoma Targeted Therapy Glioblastoma Ovarian Cancer Gastrointestinal Cancer Metabolic Pathways Tumor Biology Tumor Mapping RAS Genes Cellular Behavior Mutations Adenoid Cystic Carcinoma Colorectal Cancer Early-Onset Cancers

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

New reports highlight blood biomarkers to flag likely responders, with interferon gamma linked to the longest survivors in early testing.

Five Protein Mutation Signatures Shape Tumor Immune Visibility

New CAR T Strategy Targets Tumor Macrophages, Triggers Antitumor Immunity in Mice

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Scientists Reveal How Gut Toxin Colibactin Cross-Links DNA in Colorectal Cancer

Crescent, Kelun-Biotech Trade Cancer Asset Rights in Cross-Border Deal as Crescent Secures $185 Million

CRISPR Knockout of NRF2 Reverses Chemotherapy Resistance in Lung Cancer Models

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Study Ties CGRP–RAMP1 Signaling to GI Tumor Growth, Pointing to Repurposed Migraine Therapies

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Study Reveals How Tumor Bacteria Induce Quiescence to Thwart Cancer Treatment

KAIST Links Enlarged Cancer Nuclei to Replication Stress That Slows Metastasis in Mice

ALK7 Identified as Driver of Pancreatic Cancer’s Bloodstream Entry in Preclinical Study

Basal Stem-Like Cells Identified as Source of Small Cell Lung Cancer in Duke-Led Nature Study

Cancer Cells Use Alternate Ketone Route to Generate Acetyl-CoA for Growth

MD Anderson Debuts PreCiSE, a Genome-Wide CRISPR Platform for Primary NK Cells

Tumor-Induced Nerve Injury Identified as Driver of Anti–PD-1 Resistance

Blocking DKK1 Reprograms Neutrophils and Revives Immunotherapy in Bone Metastases

UNC Researchers Unveil Dual-Silencing RNAi Boosting Tumor Cell Killing Forty-Fold

Preclinical Studies Confirm NKAPL as Lung Cancer Tumor Suppressor, Prompt Demethylation Therapy Development